This announcement is a separate document:
沃森生物:北京国枫(上海)律师事务所关于公司2024年第一次临时股东大会的法律意见书
Walvax Biotechnology: Peking Guofeng (Shanghai) Law Firm's Legal Opinion Regarding the First Extraordinary Shareholders' Meeting of the Company in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.